Elmet Group

Preliminary trading in shares of The Elmet Group, which manufactures critical components for the defense, aerospace and energy industries, began in the trading system for Freedom clients. Later on April 23, the company's securities will appear on the Nasdaq exchange under the ticker ELMT. To participate, click on the ticker <a href="https://tap.freedom24.com/to/quote/ELMT.US?utm_source=stocks&amp;utm_medium=ELMT.US&amp;utm_campaign=pfu17895694">ELMT</a>.

Elmet Group IPO: Shares of the critical components supplier began trading

OpenAI shares have risen just 3% since the beginning of April amid a downturn in excitement around ChatGPT 

'Total wild card': Anthropic's OTC valuation soars to $1 trillion - higher than OpenAI's

Elon Musk's SpaceX plans to create space data processing centers for artificial intelligence, as well as - the creation of human settlements on the Moon and Mars are based on untested technologies and may not be commercially viable. The company warned of this in a confidential filing with the U.S. Securities and Exchange Commission (SEC) ahead of going public. The document <a href="https://www.reuters.com/world/spacex-says-unproven-ai-space-data-centers-may-not-be-commercially-viable-filing-2026-04-21/">was reviewed by</a> Reuters.

SpaceX warned of risk of 'non-viability' of AI data centers in space - Reuters

Yesway

Premarket trading in Yesway (YSWY) has started on the Freedom trading platform. Later on Wednesday, the company’s shares will debut on the Nasdaq Global Select Market under the symbol YSWY (Freedom clients: to trade, click on <a href="https://tap.freedom24.com/to/quote/YSWY.US?utm_source=stocks&amp;utm_medium=YSWY.US&amp;utm_campaign=pfu17895694">YSWY</a>).

Yesway IPO: Convenience store operator debuts on the Nasdaq

National Healthcare Properties

The REIT has listed on Nasdaq under the ticker NHP

National Healthcare IPO: fund investing in senior campuses goes public

The penalty if SpaceX backs out of the deal would be one of the largest in history

SpaceX has won the right to buy Anthropic's rival startup Cursor for $60 billion

Apple Inc.

Amazon.com, Inc.

NVIDIA Corporation

Apple <a href="https://oninvest.com/article/v-sfere-ii-vse-gotovo-dla-peredaci-vlasti-cto-smena-gendirektora-znacit-dla-apple">announced</a> that CEO Tim Cook will step down on September 1 after more than a decade at the helm of the company. Jeff Bezos-backed startup Project Prometheus is close to raising $10 billion at a valuation of $38 billion. These and other topics are covered in our review of key events for the morning of April 21.

Highlights for this morning: Tim Cook steps down as Apple CEO, Bezos' startup raises $10 billion

Ahead of listing, Revolut wants to build confidence in the bank

Revolut will not go public until 2028 at the earliest - Storonsky

Madison Air Solutions

Arxis, Inc. Class A Common Stock

Kailera Therapeutics

Investment guru Bill Ackman has set a late April IPO pricing date for his Pershing Square fund. Madison Air Solutions shares jumped 18% after the largest U.S. industrial IPO in nearly 30 years. The Warsaw exchange is ready to work with competitors in Eastern and Central Europe to keep local companies from floating in the West. The main IPO market events of the week are in our selection.

Record listing since the 20th century and Ekman's roadshow: what's important about IPOs by April 19

Artificial intelligence processor developer Cerebras Systems, which competes with Nvidia in the fast-growing chip market, has filed <a href="https://www.sec.gov/Archives/edgar/data/2021728/000162828026025762/cerebras-sx1april2026.htm">for</a> an initial public offering on the Nasdaq exchange under the ticker CBRS.

Nvidia's rival AI chip developer Cerebras has filed for an IPO

Eli Lilly and Company

Shares of biotech Kailera Therapeutics Inc. are available for trading on the Freedom client trading platform. The company’s lead asset, ribupatide, is part of the multibillion-dollar race for weight-loss drugs, a market expected to exceed $150 billion over the next decade. Later on Friday, the stock will start regular-session trading on the Nasdaq under the ticker symbol <a href="https://tap.freedom24.com/to/quote/HMH.US?utm_source=stocks&amp;utm_medium=HMH.US&amp;utm_campaign=pfu17521958">KLRA</a>.

Kailera Therapeutics IPO: Shares of obesity drugmaker start trading

Alamar Biosciences

Preliminary trading in shares of biotech company Alamar Biosciences, a protein sequencing company that enables disease research and diagnosis, has begun on the Freedom client trading system. Alamar is one of several biotech companies that have continued to go public this year despite volatile market conditions, Reuters <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/kailera-alamar-launch-us-ipos-biotech-listings-gather-momentum-2026-04-13/">notes</a>. Later on April 17, Alamar Biosciences securities will appear on the Nasdaq exchange under the ticker ALMR. To participate, click on the ticker <a href="https://tap.freedom24.com/to/quote/HMH.US?utm_source=stocks&amp;utm_medium=HMH.US&amp;utm_campaign=pfu17521958">ALMR</a>.